V029-4343 Screening compound: 1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one

V029-4343 Screening compound: 1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one
V029-4343 Screening compound: 1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-4343
1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-4343

Molecular Formula

C31H31F4N3O (C31 H31 F4 N3 O)

Compound Name

1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one

IUPAC name

1-(4-ethylpiperazin-1-yl)-3-{1-[(4-fluorophenyl)methyl]-1H-indol-3-yl}-3-[4-(trifluoromethyl)phenyl]propan-1-one

SMILES

CCN(CC1)CCN1C(CC(c1cn(Cc(cc2)ccc2F)c2c1cccc2)c1ccc(C(F)(F)F)cc1)=O

InChI

InChI=1S/C31H31F4N3O/c1-2-36-15-17-37(18-16-36)30(39)19-27(23-9-11-24(12-10-23)31(33,34)35)28-21-38(29-6-4-3-5-26(28)29)20-22-7-13-25(32)14-8-22/h3-14,21,27H,2,15-20H2,1H3/t27-/m1/s1

InChI Key

RNWCHJXUAWOJLS-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD19778389

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

537.6

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.776

Distribution Coefficient, logD

5.455

Water Solubility, LogSw

-5.77

Polar Surface Area

21.357

Acid Dissociation Constant (pKa)

22.30

Base Dissociation Constant (pKb)

7.44

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.30

V029-4343 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Indole Derivatives (10091 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with V029-4343 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-4343?
Check Price and Availability of V029-4343, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-4343 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-4343
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-4343
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-4343 available by request